1 min read
Add as a preferred source on Google

Theriva Biologics Sets 1-for-30 Reverse Split for Dec. 1, 2026

The split will take effect after the market closes, with shares scheduled to begin split-adjusted trading Dec. 2.

Thirty blank certificates align into one compact stack / TokenPost.ai
Thirty blank certificates align into one compact stack / TokenPost.ai

Theriva Biologics (TOVX) announced a 1-for-30 reverse stock split scheduled to take effect after the market closes Dec. 1, 2026. The company’s shares are set to begin trading on a split-adjusted basis Dec. 2.

Under the announced ratio, every 30 existing shares will be combined into one share. The change is scheduled to take effect after the market closes on Dec. 1.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…